Bio Reports
Eurofins Biomnis Develops LC MS MS Method For Detecting Cereulide Toxin In Human Stool Samples
Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announ...
March 12, 2026 | News
Ascletis Reports Positive Phase II Results For Monthly ASC30 Injection In Obesity Treatment
- ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of ...
March 11, 2026 | News
Lynk Pharmaceuticals Reports Positive Phase III Results For Zemprocitinib In Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammat...
March 03, 2026 | News
Genentech Reports Phase III Success For Fenebrutinib With 51 Percent Relapse Reduction In Multiple Sclerosis
- FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relap...
March 03, 2026 | News
Blueprint Medicines Showcases Four Year AYVAKIT Data Reinforcing Durable Benefit In Indolent Systemic Mastocytosis
-- Real-world study of AYVAKIT highlights improvement across ISM symptoms -- -- 12 data presentations at 2026 AAAAI Annual Meeting reflect company's ...
March 02, 2026 | Report
Gilead Reports Positive Phase 3 Data For Investigational Bictegravir And Lenacapavir Single Tablet Regimen
– Novel Investigational Combination Pairs Bictegravir, a Global Guideline-Recommended Integrase Strand Transfer Inhibitor with a High Barrier ...
February 27, 2026 | News
Illumina Outlines NovaSeq X Roadmap With 40 Percent Output Increase And Q70 Quality Milestone
40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolle...
February 26, 2026 | News
NEXT Life Sciences Advances Two Non Hormonal Male Contraceptives Into Phase II Trials
Men have long been waiting for new male contraceptive options outside of just condoms and vasectomy. Non-hormonal methods at the forefront of male interest...
February 23, 2026 | News
YolTech Reports Positive Interim Data For YOLT 202 In Alpha 1 Antitrypsin Deficiency
Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with ...
February 23, 2026 | News
Takeda Reports Positive Phase 3 KEPLER Data For ENTYVIO In Pediatric Ulcerative Colitis
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conven...
February 23, 2026 | News
P Cure Reports First Prospective Clinical Evidence Supporting Gantry Less Upright Proton Therapy For Lung Cancer Re Irradiation
P-Cure, a supplier of compact, gantry-less proton therapy systems, announced the first-ever prospective clinical results demonstrating the feasibility, saf...
February 18, 2026 | News
Eli Lilly And Company Reports Statistically Significant Event Free Survival Benefit With Selpercatinib In Early Stage RET Fusion Positive NSCLC
Selpercatinib demonstrated a highly statistically significant and clinically meaningful improvement in reducing the risk of disease recurrence or deat...
February 18, 2026 | News
Jyong Biotech Strengthens Preventive Medicine Position With Positive Phase II Data And Asian Expansion
Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modul...
February 16, 2026 | News
QIAGEN Study Shows QuantiFERON TB Gold Plus Improves Cost Effectiveness Of HIV TB Screening In Thailand
Peer-reviewed health-economic analysis evaluates tuberculosis infection (TBI) screening strategies among people living with HIV in Thailand Quanti...
February 13, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
